Also trades as: EFTRW (NASDAQ) · $vol 0M
EFTR Earnings
eFFECTOR Therapeutics, Inc.
1W: +0.0%
1M: -75.0%
3M: -66.7%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Next Earnings
2026-11-17
EPS Estimate
$-6.40
Range: $-6.40 - $-6.40
Revenue Estimate
$100K
1 analysts
Estimate vs Actual
Earnings Surprise History
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | quarter | 2029-03-31 | $-2.17 | $-2.82 | ▼ 0.66 | $— | $— |
| 2026-10-01 | quarter | 2029-06-30 | $-2.02 | $-2.17 | ▼ 0.14 | $— | $— |
| 2026-10-01 | quarter | 2027-03-31 | $-5.93 | $-6.01 | ▼ 0.08 | $280,000 | $100,000 |
| 2026-10-01 | quarter | 2026-12-31 | $-6.01 | $-6.40 | ▼ 0.39 | $100,000 | $100,000 |
| 2026-10-01 | quarter | 2030-03-31 | $— | $-0.87 | ▼ 0.87 | $— | $— |
| 2026-10-01 | quarter | 2027-12-31 | $-5.95 | $-5.35 | ▲ 0.60 | $664,400 | $802,750 |
| 2026-10-01 | quarter | 2027-06-30 | $-4.03 | $-5.93 | ▼ 1.90 | $420,000 | $280,000 |
| 2026-10-01 | quarter | 2028-09-30 | $-3.08 | $-4.95 | ▼ 1.87 | $— | $— |
| 2026-10-01 | quarter | 2029-09-30 | $-1.95 | $-2.02 | ▼ 0.07 | $— | $— |
| 2026-10-01 | quarter | 2028-12-31 | $-2.82 | $-3.08 | ▼ 0.26 | $— | $— |
| 2026-10-01 | quarter | 2027-09-30 | $-5.35 | $-4.03 | ▲ 1.32 | $802,750 | $420,000 |
| 2026-10-01 | quarter | 2029-12-31 | $-0.87 | $-1.95 | ▼ 1.08 | $— | $— |
| 2026-10-01 | quarter | 2028-06-30 | $-4.95 | $-5.08 | ▼ 0.13 | $— | $— |
| 2026-10-01 | quarter | 2028-03-31 | $-5.08 | $-5.95 | ▼ 0.87 | $— | $664,400 |
| 2026-08-11 | annual | 2022-12-31 | $— | $-14.29 | ▼ 14.29 | $— | $3,551,600 |
Earnings Call Transcripts
No transcripts available.